Sabiia Seb
PortuguêsEspañolEnglish
Embrapa
        Busca avançada

Botão Atualizar


Botão Atualizar

Ordenar por: 

RelevânciaAutorTítuloAnoImprime registros no formato resumido
Registros recuperados: 2
Primeira ... 1 ... Última
Imagem não selecionada

Imprime registro no formato completo
Controlling Campylabacter in the Chicken Meat Chain: A Cost-Utility Analysis AgEcon
Mangen, Marie-Josee J.; Havelaar, Arie H.; Nauta, Maarten J.; de Koeijer, Aline A.; de Wit, G. Ardine.
The aim of this study was the estimation of cost-utility of interventions to control Campylobacter contamination of broiler meat. The relative risk, the intervention costs, the disease burden (expressed in DALYs) and the costs-of-illness for the various interventions were necessary inputs for the cost-utility analysis. The cost-utility is expressed in net costs per reduced DALY. The most cost-effective interventions are: reduction of faeces leakage in the slaughter line and decontamination of the carcass by dipping in a chemical solution. Phage therapy might be another cost-effective intervention, depending on assumed costs/chicken. Irradiation is the most efficient intervention, but the least cost-effective.
Tipo: Conference Paper or Presentation Palavras-chave: Food safety; Cost-utility; Disease burden; Campylobacter; Chicken meat; Food Consumption/Nutrition/Food Safety; D61; D81; I18.
Ano: 2005 URL: http://purl.umn.edu/24763
Imagem não selecionada

Imprime registro no formato completo
Estimating the Costs and the Disease Burden Associated With Campylobacter Infections and Sequelae in the Netherlands AgEcon
Mangen, Marie-Josee J.; Havelaar, Arie H.; de Wit, G. Ardine; Bernsen, Rob A.J.A.M.; van Koningsveld, Rinske.
Campylobacter infections pose an important public health problem in the Netherlands. Approximately 79,000 persons per year are estimated to experience symptoms of acute gastroenteritis. Further annually some 1400 ReA cases, 60 GBS cases and 11 IBD cases are associated with a previous Campylobacter infection. Using a stochastic simulation model the disease burden and the cost-of-illness of Campylobacter infections and its sequelae were estimated. Estimates of the Campylobacter-associated disease burden and costs-of-illness were 1185 DALYs (90% C.I. 693 - 1845 DALYs) per year and some 21 million E (90% C.I. 10 - 38 million E) per year respectively.
Tipo: Conference Paper or Presentation Palavras-chave: Campylobacter; Sequelae; Cost-of-illness; Disease burden; Netherlands; Food Consumption/Nutrition/Food Safety.
Ano: 2004 URL: http://purl.umn.edu/24985
Registros recuperados: 2
Primeira ... 1 ... Última
 

Empresa Brasileira de Pesquisa Agropecuária - Embrapa
Todos os direitos reservados, conforme Lei n° 9.610
Política de Privacidade
Área restrita

Embrapa
Parque Estação Biológica - PqEB s/n°
Brasília, DF - Brasil - CEP 70770-901
Fone: (61) 3448-4433 - Fax: (61) 3448-4890 / 3448-4891 SAC: https://www.embrapa.br/fale-conosco

Valid HTML 4.01 Transitional